![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | C2orf49 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | C9h2orf49 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of C9H2ORF49 mRNA | CTD | PMID:33387578 | C2orf49 | Human | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of C2ORF49 mRNA | CTD | PMID:27153756 | C2orf49 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of C2ORF49 mRNA | CTD | PMID:21632981 and PMID:26238291 | C2orf49 | Human | bisphenol A | increases expression | ISO | C9h2orf49 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of C2ORF49 mRNA | CTD | PMID:25181051 | C2orf49 | Human | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of C2ORF49 mRNA | CTD | PMID:26079696 | C2orf49 | Human | cadmium dichloride | decreases expression | ISO | C9h2orf49 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of C9H2ORF49 mRNA | CTD | PMID:19010381 | C2orf49 | Human | copper atom | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of C2ORF49 mRNA | CTD | PMID:24690739 | C2orf49 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of C2ORF49 mRNA | CTD | PMID:24690739 | C2orf49 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of C2ORF49 mRNA | CTD | PMID:19549813 | C2orf49 | Human | coumarin | increases phosphorylation | EXP | | 6480464 | coumarin results in increased phosphorylation of C2ORF49 protein | CTD | PMID:35688186 | C2orf49 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of C2ORF49 mRNA | CTD | PMID:22147139 and PMID:25562108 | C2orf49 | Human | cylindrospermopsin | increases expression | EXP | | 6480464 | cylindrospermopsin results in increased expression of C2ORF49 mRNA | CTD | PMID:24921660 | C2orf49 | Human | disulfiram | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in decreased expression of C2ORF49 mRNA | CTD | PMID:24690739 | C2orf49 | Human | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of C2ORF49 mRNA | CTD | PMID:35967413 | C2orf49 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | C2orf49 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of C2ORF49 mRNA | CTD | PMID:29803840 | C2orf49 | Human | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of C2ORF49 mRNA | CTD | PMID:26272509 | C2orf49 | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C2ORF49 mRNA | CTD | PMID:27188386 | C2orf49 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of C2ORF49 mRNA | CTD | PMID:20655997 | C2orf49 | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of C2ORF49 protein | CTD | PMID:37730182 | C2orf49 | Human | hexadecanoic acid | increases phosphorylation | EXP | | 6480464 | Palmitic Acid results in increased phosphorylation of C2ORF49 protein | CTD | PMID:28073184 | C2orf49 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of C2ORF49 protein | CTD | PMID:32959892 | C2orf49 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of C2ORF49 mRNA | CTD | PMID:23649840 | C2orf49 | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of C2ORF49 mRNA | CTD | PMID:28001369 | C2orf49 | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of C2ORF49 mRNA | CTD | PMID:35430440 | C2orf49 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of C2ORF49 mRNA | CTD | PMID:27188386 | C2orf49 | Human | quercitrin | decreases expression | EXP | | 6480464 | quercitrin results in decreased expression of C2ORF49 mRNA | CTD | PMID:25193878 | C2orf49 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | C2orf49 | Human | silicon dioxide | decreases methylation | EXP | | 6480464 | Silicon Dioxide results in decreased methylation of C2ORF49 gene | CTD | PMID:34973136 | C2orf49 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of C2ORF49 mRNA | CTD | PMID:31533062 | C2orf49 | Human | testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of C2ORF49 mRNA | CTD | PMID:33359661 | C2orf49 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of C2ORF49 mRNA | CTD | PMID:28818685 | C2orf49 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of C2ORF49 mRNA | CTD | PMID:23179753 | C2orf49 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of C2ORF49 mRNA | CTD | PMID:27188386 | C2orf49 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of C2ORF49 mRNA | CTD | PMID:23179753 more ... | C2orf49 | Human | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of C2ORF49 gene | CTD | PMID:29154799 | C2orf49 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of C2ORF49 mRNA | CTD | PMID:25979313 | C2orf49 | Human | vinclozolin | increases expression | ISO | C9h2orf49 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of C9H2ORF49 mRNA | CTD | PMID:23034163 | |